Bivalirudin for Injection 250 mg, 10 Single-Dose Vials, Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-275-67.
Published July 19, 2023 · Recall initiated: July 3, 2023
Summary
FDA records drug Class II recall D-0918-2023, published July 19, 2023 and initiated July 3, 2023. Recalling firm: Accord Healthcare, Inc.; Status: Terminated; Reported quantity: 1680 vials; Lot: Lot #: M2212070 Exp. date 08/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Particulate matter identified as fiber.
What to do
Voluntary: Firm initiated · Letter
Get an email if BIVALIRUDIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BIVALIRUDIN
- Manufacturer
- Accord Healthcare, Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0316729275033
- Lot
- Lot #: M2212070 Exp. date 08/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAtropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials, Rx only,July 19, 2023
- FDAArtificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle,July 19, 2023
- FDA0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medical Inc. Bethlehem, PAJuly 19, 2023
- FDAArtificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle,July 19, 2023
- FDABig Machine Distillery Hand Sanitizer Non-Sterile Solution Alcohol Antiseptic 80% Topical Solution, ProducedJuly 19, 2023
- FDADelsam Pharma's ARTIFICIAL TEARS (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1%, 1/2July 19, 2023
Questions about this recall
Was Bivalirudin for Injection 250 mg, 10 Single-Dose Vials, Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-275-67. recalled?
Yes. FDA published recall D-0918-2023 on July 19, 2023. Reported hazard: Presence of Particulate Matter: Particulate matter identified as fiber.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BIVALIRUDIN. UPC: 0316729275033.